Axsome Therapeutics Inc (AXSM) Event Oct. 10, 2022, 04:03 UTC 130 0 comments Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022 Comment Full text
Passage Bio Inc (PASG) Event Oct. 10, 2022, 04:02 UTC 133 0 comments Passage Bio, Inc. - Corporate Presentation - October 2022 Comment Full text
Compugen Ltd (CGEN) Event Oct. 07, 2022, 09:20 UTC 130 0 comments Compugen - Video Recording of Immuno UK Presentation Available Comment Full text
Allogene Therapeutics Inc (ALLO) Event Oct. 06, 2022, 20:20 UTC 46 1 comments (10% Negative) Allogene Therapeutics, Inc. (ALLO) Announces Clinical Trial Timeline Adjustment Comment Full text
Mirum Pharmaceuticals Inc (MIRM) Event Oct. 06, 2022, 10:41 UTC 133 0 comments Mirum Pharma - Corporate Presentation – October 2022 Comment Full text
Seagen Inc (SGEN) Event Oct. 06, 2022, 05:03 UTC 129 0 comments Seagen - Third Quarter 2022 Financial Results Comment Full text
Taysha Gene Therapies (TSHA) Event Oct. 06, 2022, 04:03 UTC 134 0 comments Taysha Gene Therapies Announces Presentationsat the Upcoming 29th Annual Meeting ofthe European Society of Gene & CellTherapy (ESGCT) Comment Full text
Compugen Ltd (CGEN) Event Oct. 06, 2022, 04:02 UTC 130 0 comments Compugen - Compugen to Present New Clinical and Research Data in Two Oral Presentations at SITC 2022 Comment Full text
Cellectis (CLLS) Event Oct. 05, 2022, 20:30 UTC 34 1 comments (99% Neutral) Cellectis (CLLS) Files Form 6-K Comment Full text
ChemoCentryx Inc (CCXI) Event Oct. 05, 2022, 05:32 UTC 130 0 comments ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting Comment Full text